World Health Organisation says Gilead's drug remdesivir is not recommended for patients hospitalised with COVID-19
- regardless of how ill they are
- there is no evidence it improves survival or reduces the need for ventilation
Most Popular
Stock Daily Updates
Top Forex Brokers
Must Read